BioTrinity 2024
Syneos Health is a dedicated partner to the UK biotech sector, providing clinical, medical affairs and commercial solutions to partners at all stages of the asset development continuum.
We have vast experience working side by side with biotech companies in nearly every therapeutic category, in the UK and globally, and across all points along the product development continuum. We are uniquely positioned to address ever-evolving biotech dynamics and have an unrelenting commitment to your success.
Meet with Us
Our team will be at BioTrinity 2024! Find us at booth #1 or schedule a meeting to learn how you can have access to a truly cross-functional team of experts, fully committed to your success, providing a comprehensive and holistic approach to your asset needs.
Speaker Session
Cardiovascular & Metabolic Disease R&D Spotlight
April 24 | 11:00am BST
Tammy D’Lugin Monroe
Senior Vice President, Chief of Staff to the Chief Scientific Officer, Syneos Health
Ruth Henrice-Desrosiers, MD, MS
Medical Director, Medical Management and Scientific Services, Syneos Health
Related Content
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
BLOG | Mastering the Art of a Product Launch: Insights for Biopharma Commercialization Teams
Syneos Health Podcast | Investing for Commercial Success as an Emerging Company
Why Do Sponsors Terminate Clinical Trials...and at What Cost?
Webinar | How AI is Supercharging Clinical Trials
The Win-Win of End-to-End Outsourcing for Emerging Biotech
